Incidence of acute myeloid leukemia after breast cancer.
Breast cancer is the most frequent cancer among women and the leading cause of death among middle-aged women. Early detection by mammography screening and improvement of therapeutic options have increased breast cancer survival rates, with the consequence that late side effects of cancer treatment become increasingly important. In particular, patients treated with adjuvant chemotherapy regimens, commonly including alkylating agents and anthracyclines, are at increased risk of developing leukemia, further enhanced by the use of radiotherapy. In the last few years also the use of growth factors seems to increase the risk of secondary leukemia. The purpose of this review is to update epidemiology of therapy-related myeloid neoplasms occurring in breast cancer patients.
Hematology Institute, Catholic University, Rome, Italy.
Caterina Giovanna
CG
Valentini
Luana
L
Fianchi
Maria Teresa
MT
Voso
Morena
M
Caira
Giuseppe
G
Leone
Livio
L
Pagano